Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors

WB Campbell, JR Falck - Hypertension, 2007 - Am Heart Assoc
WB Campbell, JR Falck
Hypertension, 2007Am Heart Assoc
The endothelium regulates vascular tone through the release of a number of soluble
mediators, including NO, prostaglandin I2, and endothelium-derived hyperpolarizing factor.
Epoxyeicosatrienoic acids are cytochrome P450 epoxygenase metabolites of arachidonic
acid. They are synthesized by the vascular endothelium and open calcium-activated
potassium channels, hyperpolarize the membrane, and relax vascular smooth muscle.
Endothelium-dependent relaxations to acetylcholine, bradykinin, and shear stress that are …
The endothelium regulates vascular tone through the release of a number of soluble mediators, including NO, prostaglandin I2, and endothelium-derived hyperpolarizing factor. Epoxyeicosatrienoic acids are cytochrome P450 epoxygenase metabolites of arachidonic acid. They are synthesized by the vascular endothelium and open calcium-activated potassium channels, hyperpolarize the membrane, and relax vascular smooth muscle. Endothelium-dependent relaxations to acetylcholine, bradykinin, and shear stress that are not inhibited by cyclooxygenase and NO synthase inhibitors are mediated by the endothelium-derived hyperpolarizing factor. In arteries from experimental animals and humans, the non-NO, non-prostaglandin-mediated relaxations and endothelium-dependent hyperpolarizations are blocked by cytochrome P450 inhibitors, calcium-activated potassium channel blockers, and epoxyeicosatrienoic acid antagonists. Acetylcholine and bradykinin stimulate epoxyeicosatrienoic acid release from endothelial cells and arteries. These findings indicate that epoxyeicosatrienoic acids act as endothelium-derived hyperpolarizing factors and regulate arterial tone.
Am Heart Assoc